Submitted by Anonymous (not verified) on 5 October 2023 - 16:35
Opinion/decision on a Paediatric investigation plan (PIP): 3,6-diamino-2,5-bis{N-[(1R)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrazine (MB-102), decision type: , therapeutic area: , PIP number: P/0457/2022
Source: